Start free

Oric Pharmaceuticals, Inc. (ORIC) insider trading

Recent insider transactions reported to the SEC on Form 4 — directors and officers buying or selling their own company’s stock. Sourced directly from public SEC filings, latest filed Oct 21, 2026.

Filings shown
7
Open-market buys
0
Open-market sells
10

Counts cover the 7 most recent Form 4 filings Tradune holds for ORIC (filed Jul 8 – Oct 21, 2026); the score below covers only the trailing 90 days (0 buys, 7 sells). SEC EDGAR Form 4 filings for ORIC last checked Nov 21, 2026, 09:00 UTC; the latest ORIC filing Tradune holds was filed Oct 21, 2026. This is not guaranteed to be the complete record — see ORIC's full Form 4 filing history on SEC EDGAR.

Open-market activity, last 90 days

Purchases (Form 4 code P) and sales (code S) on the 5 filings Tradune holds for ORIC filed Aug 28 – Oct 21, 2026. Grants, exercises, tax withholding and the other Form 4 transaction codes are left out.

7 open-market sales by Rule 10b5-1 checkbox

On filings with the 10b5-1 box checked
7 sales· 111,700 sh
checkbox disclosed
On filings with the box not checked
0 sales· 0 sh
not proof that no plan exists
Not comparable
0 sales· 0 sh
filed before Apr 1, 2023, or no checkbox value in the filing data

Counts are Form 4 lines as filed. The checkbox is one per filing, so every sale on a filing with the box checked is counted there even if only some of its transactions were under a plan; it records what the filer disclosed, and the three categories are not a judgement about why a sale was made.

Open-market purchases and sales by insider
Insider Buys Sells Shares bought Shares sold Value
Dominic PiscitelliChief Financial Officer 0 5 — 105,000 −$1,432,565
Richard A. HeymanDirector 0 2 — 6,700 −$86,524

Value = shares × the price reported on each Form 4 (+ purchases, − sales); every open-market line in this window disclosed a price.

Insider-activity score

0/ 100

Net insider sales
0 distinct buyers0 buy · 7 sell tx

Summarises ~90 days of public SEC Form 4 activity — more distinct buyers, officer involvement and net buying score higher. A description of filing activity, not a rating or buy signal. How this score is computed →

Get alerted when insiders buy the stocks you own

Add your holdings — no brokerage login — and Insider Radar sends a Telegram alert when an open-market Form 4 buy of $100,000 or more is filed on a stock you hold or watch.

Free for everyone right now · no card · nothing to buy

Start free

How to read this: an open-market purchase (Form 4 code P) is a buy at the market price with the insider’s own money, as opposed to a grant, award or option exercise; an open-market sale is code S. When two or more distinct insiders report open-market purchases in the same 90-day window, this site labels that a cluster — a definition, not a forecast; see insider cluster buying. “Held after” is Form 4 Table I column 5; “Change” = shares ÷ holdings before the trade (held after − shares for an acquisition, held after + shares for a disposition).

Insider Buying at ORIC

No open-market insider purchases (Form 4 code P) were reported for ORIC between Jul 8, 2026 and Oct 21, 2026. The filings below may include other transaction types — sales, grants, option exercises, and tax withholding — shown for completeness; they are not open-market purchases.

Recent Form 4 filings

Source: SEC EDGAR Form 4 · transaction codes explained

Dominic Piscitelli Chief Financial Officer · filed Oct 21, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Option exercise 14,000 $4.36 83,828 +20% Oct 20, 2026
Open-market sale 10b5-1 box checked 14,000 $13.53 69,828 −17% Oct 20, 2026
Option exercise Stock Option (right to buy) 14,000 — — — Oct 20, 2026

† change in this filer’s own reported holding line (Form 4 Table I, col. 5), not of total company ownership; small prior holdings produce large percentages, so under 100 shares the prior holding is shown instead.

“10b5-1 box checked” = the filer checked the Form 4 box stating that a transaction on the filing was made under a plan intended to satisfy Rule 10b5-1(c); “10b5-1 box not checked” = the box was left blank, which does not prove that no plan exists. The box applies to Form 4s filed from April 1, 2023; older filings, and boxes we could not read, carry no tag. What the 10b5-1 box means.

Richard A. Heyman Director · filed Oct 2, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box checked 3,200 $12.91 203,472 (indirect) −1.5% Oct 1, 2026
Option exercise Stock Option (right to buy) 3,500 — — — Oct 1, 2026
Open-market sale 10b5-1 box checked 3,500 $12.91 38,300 −8.4% Oct 1, 2026
Option exercise 3,500 $1.60 41,800 +9.1% Oct 1, 2026
Dominic Piscitelli Chief Financial Officer · filed Sep 29, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box checked 13,400 $13.53 69,828 −16% Sep 28, 2026
Option exercise 13,400 $4.36 83,228 +19% Sep 28, 2026
Option exercise Stock Option (right to buy) 13,400 — — — Sep 28, 2026
Dominic Piscitelli Chief Financial Officer · filed Sep 25, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box checked 500 $13.51 69,828 −0.7% Sep 24, 2026
Option exercise 600 $4.36 70,428 +0.9% Sep 24, 2026
Open-market sale 10b5-1 box checked 100 $13.50 70,328 −0.1% Sep 24, 2026
Option exercise Stock Option (right to buy) 600 — — — Sep 24, 2026
Dominic Piscitelli Chief Financial Officer · filed Aug 28, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Option exercise 52,000 $4.36 121,828 +74% Aug 26, 2026
Option exercise Stock Option (right to buy) 25,000 — — — Aug 26, 2026
Option exercise Stock Option (right to buy) 52,000 — — — Aug 26, 2026
Open-market sale 10b5-1 box checked 77,000 $13.69 69,828 −52% Aug 26, 2026
Option exercise 25,000 $6.00 146,828 +21% Aug 26, 2026
Richard A. Heyman Director · filed Jul 28, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Option exercise 3,500 $1.60 45,300 +8.4% Jul 24, 2026
Option exercise Stock Option (right to buy) 3,500 — — — Jul 24, 2026
Open-market sale 10b5-1 box checked 6,100 $12.02 206,672 (indirect) −2.9% Jul 24, 2026
Open-market sale 10b5-1 box checked 7,000 $12.02 38,300 −15% Jul 24, 2026
Richard A. Heyman Director · filed Jul 8, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box checked 300 $12.00 212,772 (indirect) −0.1% Jul 6, 2026

Insider filings reported around the same time

Other companies whose most recent Form 4 was filed closest to ORIC's (Oct 21, 2026).

Frequently asked about ORIC insider activity

How many insiders bought ORIC stock in these Form 4 filings?

No open-market purchases (Form 4 code P) of ORIC shares were reported by Oric Pharmaceuticals, Inc. insiders between Jul 8, 2026 and Oct 21, 2026. The 7 filings shown on this page cover other transaction types — sales, grants, option exercises, and tax withholding.

Who filed the most recent Form 4 for ORIC?

The most recent Form 4 on this page was filed by Dominic Piscitelli (Chief Financial Officer) on Oct 21, 2026, reporting 3 transactions. The original document is linked from the filing list above on SEC EDGAR. Amended filings (Form 4/A) may later revise reported figures.

What was the largest open-market ORIC insider sale shown?

The largest open-market sale among the filings shown was 77,000 ORIC shares at $13.69 (about $1,053,814) by Dominic Piscitelli (Chief Financial Officer) on Aug 26, 2026. Value is shares × the price reported on the Form 4; that Form 4 has the Rule 10b5-1 box checked.

New to Form 4s? The transaction codes, the 90-day window and the 0–100 score are defined on the insider-activity score methodology page.

Get insider alerts for ORIC — and your whole portfolio

Tradune watches SEC Form 4 filings and flags insider-cluster buying across everything you hold, routed to you automatically. Free for everyone right now · no card · nothing to buy

This score summarizes SEC Form 4 filing activity over the trailing 90 days. It is descriptive, not predictive — not a rating, recommendation, or investment advice. Data: SEC EDGAR (public domain), as filed; amendments may revise figures. Tradune is not a registered investment adviser.

Data as filed; amended filings (Form 4/A) may revise figures. Sales may occur under prearranged Rule 10b5-1 trading plans.